KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Other Non Operating Income (2016 - 2025)

AbbVie (ABBV) has disclosed Other Non Operating Income for 14 consecutive years, with -$5.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 3730.67% to -$5.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.8 billion, a 178.78% decrease, with the full-year FY2025 number at -$5.8 billion, down 78.8% from a year prior.
  • Other Non Operating Income was -$5.7 billion for Q4 2025 at AbbVie, down from -$20.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.5 billion in Q3 2022 to a low of -$5.7 billion in Q4 2025.
  • A 5-year average of -$752.4 million and a median of -$25.0 million in 2022 define the central range for Other Non Operating Income.
  • Biggest YoY gain for Other Non Operating Income was 7004.76% in 2022; the steepest drop was 33328.57% in 2022.
  • AbbVie's Other Non Operating Income stood at -$7.0 million in 2021, then crashed by 33328.57% to -$2.3 billion in 2022, then crashed by 95.73% to -$4.6 billion in 2023, then soared by 96.72% to -$150.0 million in 2024, then plummeted by 3730.67% to -$5.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other Non Operating Income are -$5.7 billion (Q4 2025), -$20.0 million (Q3 2025), and -$23.0 million (Q2 2025).